IP Verse

Transdermal Delivery System Comprising Buprenorphine - EP2790685

The patent EP2790685 was granted to LTS Lohmann Therapie Systeme on Aug 16, 2017. The application was originally filed on Dec 12, 2012 under application number EP12826670A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP2790685

LTS LOHMANN THERAPIE SYSTEME
Application Number
EP12826670A
Filing Date
Dec 12, 2012
Status
Granted And Under Opposition
Jul 14, 2017
Grant Date
Aug 16, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HEXALMay 16, 2018TER MEER STEINMEISTER & PARTNERADMISSIBLE
PAJAROMay 16, 2018BIRD & BIRDADMISSIBLE
SWINDELL & PEARSONMay 16, 2018FRKELLYADMISSIBLE
LUYE PHARMA SWITZERLANDMay 15, 2018KRAUS & LEDERERADMISSIBLE
LUYE PHARMA SWITZERLANDMay 15, 2018KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2010119585
INTERNATIONAL-SEARCH-REPORTUS2010119585
INTERNATIONAL-SEARCH-REPORTWO2004014336
INTERNATIONAL-SEARCH-REPORTWO9619975
OPPOSITIONDE102006054732
OPPOSITIONEP2366388
OPPOSITIONUS2008274167
OPPOSITIONUS2010112064
OPPOSITIONUS2010119585
OPPOSITIONUS5069909
OPPOSITIONUS5240711
OPPOSITIONUS6264980
OPPOSITIONWO03079962
OPPOSITIONWO2006030030
OPPOSITIONWO9619975
OPPOSITIONWO9836728
OTHEREP2790685
OTHERWO9836728

Non-Patent Literature (NPL) Citations (5) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Note for guidance on modified release oral and transdermal dosage forms: section II", The European Agency for the Evaluation of Medicinal Products Human Medicines Evaluation Unit, London, (19990728), pages 1 - 11, XP055491032-
OPPOSITION- "patches transdermal", European Pharmacopoeia, (20050100), page 616, XP055491038-
OPPOSITION- MCQUINN et al., "Sustained oral mucosal delivery in human volunteers of bu- prenorphine from a thin non-eroding mucoadhesive polymeric disk", Journal of Controlled Release, (19950000), vol. 34, doi:10.1016/0168-3659(95)00008-V, pages 243 - 250, XP004037503
OPPOSITION- C.-L. LIAO et al., "In Vitro Skin Permeation of Buprenorphine Transdermal Patch", Journal of Food and Drug Analysis, (20080000), vol. 16, no. 6, pages 8 - 15, XP009184346
OTHER- NAPP PHARMACEUTICALS LIMITED, "BUTRANS 5, 10 AND 20UG/H TRANSDERMAL PATCH", EMC, (20100311), pages 1 - 10, URL: HTTPS://WWW.MEDICINES.ORG.UK/EMC/MEDICINE/16787, XP003035774-

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents